St. Jude To Acquire CardioMEMS As FDA Approves Heart Failure Monitor
FDA approved the CardioMEMS HF wireless heart-failure monitor, and St. Jude has exercised its option to buy the technology and its manufacturer. The approval is based on the results of the CHAMPION pivotal trial, which showed that patients monitored with the remote, implantable system needed fewer hospitalizations.
St. Jude Medical Inc. announced plans to exercise its option to acquire CardioMEMS Inc. soon after FDA approved its CardioMEMS HF implantable heart failure monitoring system on May 28.
St. Jude invested $60 million for 19 percent ownership of CardioMEMS in 2010 while securing an exclusive option to purchase...